OTCMKTS:CTYX Curative Biotechnology (CTYX) Stock Price, News & Analysis $0.0089 0.00 (0.00%) As of 08/29/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Curative Biotechnology Stock (OTCMKTS:CTYX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Curative Biotechnology alerts:Sign Up Key Stats Today's Range$0.0075▼$0.008950-Day Range$0.0077▼$0.012952-Week Range$0.00▼$0.22Volume151,181 shsAverage Volume3.01 million shsMarket Capitalization$3.46 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Curative Biotechnology, Inc. engages in the provision of software solutions for the healthcare market. Its products include MedFlash, electronic Personal Health Manager, Medical Alert, personal emergency response services, product and medical transcription, disease management, revenue cycle management, and medical consulting-billing. The company was founded by Jon Pevzner on July 29, 1995 and is headquartered in Boca Raton, FL. Read More Receive CTYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CTYX Stock News HeadlinesBuy Rating Justified by Tenaya Therapeutics’ Promising Gene Therapy AdvancementsOctober 11, 2024 | markets.businessinsider.comCue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingOctober 4, 2024 | markets.businessinsider.comWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much bigger here at home. Emergency powers are being invoked, trillions are being mobilized, and the scale rivals anything we’ve seen since WWII. According to Porter Stansberry and Jeff Brown, a new economic arms race is already underway — one that could reshape markets, redirect capital, and impact billions of lives. They’ve just released an urgent briefing that explains what’s really happening behind the scenes, and which companies are positioned to benefit most.September 1 at 2:00 AM | Porter & Company (Ad)CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer TreatmentAugust 29, 2024 | markets.businessinsider.comCurative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of DirectorsOctober 31, 2023 | tmcnet.comCurative Announces Spin-Off of Sensible Diagnostics with their Game-Changing 10-Minute Point-Of-Care PCR Testing PlatformMay 17, 2023 | finance.yahoo.comSOLVE FSHD Invests in Epic Bio to Advance Potentially Curative TherapyMay 16, 2023 | finance.yahoo.comCurative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop StudyJanuary 5, 2023 | wsj.comSee More Headlines CTYX Stock Analysis - Frequently Asked Questions How have CTYX shares performed this year? Curative Biotechnology's stock was trading at $0.0128 at the beginning of 2025. Since then, CTYX shares have decreased by 30.5% and is now trading at $0.0089. How do I buy shares of Curative Biotechnology? Shares of CTYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Curative Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Curative Biotechnology investors own include Universal Display (OLED), Curative Biotechnology (CUBT), Telenav (TNAV), Semiconductor Manufacturing International (SIUIF), Cellular Biomedicine Group (CBMG), ANADIGICS (ANAD) and Intec Pharma (NTEC). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Miscellaneous Health & Allied Services Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CTYX CIKN/A Webwww.connectyx.com Phone(561) 418-7725FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares388,504,000Free FloatN/AMarket Cap$3.46 million OptionableNot Optionable Beta-33.99 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:CTYX) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curative Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curative Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTYX Stock Alerts